10 Best Freelance Biotechnology Jobs Online In September 2016 #digital #pharma

Posted On Dec 7 2017 by

#biotechnology jobs # Biotechnology Jobs Hourly – Expert ($$$) – Est. Time: Less than 1 month, Less than 10 hrs/week – Posted I need a person that specialize in Nano technology. I need convert certain compounds to the Nano size to become water soluble and to be more absorbable by humans. I need an outline how to do the processes and the equipment required. Example of a company doing what am trying to do. CBD NanoUltra CBD Nano Ultra is a water-based concentrate that can easily be added to any water-soluble product such as water and beverages. Through advanced physics …


Amgen to Buy Onyx for $10 #pharma #tutor

Posted On Dec 7 2017 by

#onyx pharma # Amgen to Buy Onyx for $10.4 Billion to Gain Cancer Drug Amgen Inc. agreed to buy Onyx Pharmaceuticals Inc. in a $10.4 billion transaction that gives Amgen access to a rapidly expanding cancer-drug market with a new product that offers sure revenue. Amgen will pay $125 a share for Onyx’s outstanding stock, the companies said in a statement yesterday. Net of estimated Onyx cash, the deal is worth $9.7 billion. Onyx’s Kyprolis, approved last year for a rare blood cancer, may spur more than $3 billion in revenue by 2021, according to analyst estimates compiled by Bloomberg. …


Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout #forest #pharma

Posted On Dec 7 2017 by

#onyx pharma # Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout SOUTH SAN FRANCISCO, Calif. ( TheStreet ) — Every biotech CEO wants to say they bought an asset for X and sold it for 10X, yet few top executives manage to create value on this mammoth scale. Onyx Pharmaceuticals’ ( ONXX ) CEO Tony Coles just did it. The 10X is Amgen ( AMGN ) paying $10 billion in cash ($125 per share) to acquire Onyx. The deal, much discussed and analyzed since June, was finally announced Sunday night. But Amgen wouldn’t be buying Onyx …


Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout #biotechnology #industry

Posted On Nov 29 2017 by

#onyx pharma # Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout SOUTH SAN FRANCISCO, Calif. ( TheStreet ) — Every biotech CEO wants to say they bought an asset for X and sold it for 10X, yet few top executives manage to create value on this mammoth scale. Onyx Pharmaceuticals’ ( ONXX ) CEO Tony Coles just did it. The 10X is Amgen ( AMGN ) paying $10 billion in cash ($125 per share) to acquire Onyx. The deal, much discussed and analyzed since June, was finally announced Sunday night. But Amgen wouldn’t be buying Onyx …


Top 10 Pharmaceutical Blogs #pharma #marketing

Posted On Nov 28 2017 by

#pharma blogs # This list includes the top 10 pharmaceutical blogs ranked by unique visitors per month and their rank changes compared to last year s list. Using Cision s media database, we compiled this list based on Cision s proprietary research. The UVPM figures are provided by Compete.com. In order to gauge readership as accurately as possible, this list does not include blogs that are hosted on a parent website, as those readership numbers may be based on readership of the website as a whole, and not the blog specifically. Pharmalot 26,317 UVPM +1 In The Pipeline 12,820 UVPM …


The Top 10 Myths About Selecting a Contract Manufacturing Partner #pharmazie

Posted On Nov 28 2017 by

#contract manufacturing # The Top 10 Myths About Selecting a Contract Manufacturing Partner With so much of today s electronics manufacturing outsourced, my team at Riverwood Solutions ends up spending a lot of time inside various contract manufacturing facilities. Sitting on a plane today heading to yet another contract manufacturing (CM) visit, I started tallying the number of CM factories, and the number of different countries my team has been in over the past year visiting CMs. I was able to quickly rattle off CM factories in 24 different countries on 5 continents that were visited by just the consulting …


Top 10 Pharma Advertising Budgets #nutri #pharma

Posted On Nov 26 2017 by

#pharma advertising # Top 10 Pharma Advertising Budgets – 2012 Direct-to-consumer (DTC) advertising, something that once seemed shocking, has become such a part of the television landscape that it raises few eyebrows any longer. Oh, there was an FDA study and finding last year that calming voice-overs and images of puppies and beach houses did not distract consumers from picking up on the health risks of the products being pitched. And a recent study found that voluntary industry guidelines have been ignored to the point that family-hour viewing often comes with a dose of erectile dysfunction drug advertising. But all …


Top 10 US – and Global – Market Research Organizations #pharma #distributors

Posted On Nov 26 2017 by

#market research companies # Top 10 US and Global Market Research Organizations July 13, 2015 – by MarketingCharts staff Notes. Nielsen and Kantar are the top market research organizations both in the US and globally, with Nielsen far and away the leader, according to separate rankings recently released by the AMA and RFL Communications. IMS Health and Ipsos S.A. also rank within the top 5 on both lists, with IBM s Information and Analytics Group coming in at #3 on RFL s global list, based on an IDC estimate. The AMA s top 10 is largely consistent from last year: …


The top 10 most expensive drugs of 2013 #alnylam #pharma

Posted On Nov 26 2017 by

#pharmaceutical companies news # The top 10 most expensive drugs of 2013 The price of Gilead Sciences’ breakthrough drug Sovaldi has drawn all of the attention this year. By pricing it at $85,000 for a 12-week course, Gilead Sciences ($GILD) has been pilloried by politicians, payers and providers. But as EvaluatePharma points out, at that price Sovaldi barely makes it into the top 20 most expensive drugs. number 19 to be exact, just above Novartis’ ($NVS) Gleevec and just below GlaxoSmithKline’s ($GSK) Mekinist. Sovaldi is pricey, but if you want to talk about really pricey, then look at the 10 …


The top 10 pharma companies in social media #pharmaceutical #industry #trends

Posted On Nov 25 2017 by

#pharma social media # The top 10 pharma companies in social media Chatting with the public is not in pharma’s comfort zone. Drugmakers are adept at the one-way communication known as direct-to-consumer advertising, and some of them deal well with the media. Some even know how to work with patient groups. Back-and-forth with doctors? Pharma’s daily bread. But put your average, everyday drug company in the middle of a public conversation, and it freezes up. Worried it will say the wrong thing, sensitive to criticism, mindful of unintended consequences, drugmakers usually prefer to stand by the punch bowl and check …